Osaic Holdings’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Buy |
43,029
+4,094
| +11% | +$14.1K | ﹤0.01% | 3849 |
|
|
2025
Q1 | $214K | Sell |
38,935
-4,886
| -11% | -$26.8K | ﹤0.01% | 3563 |
|
|
2024
Q4 | $149K | Buy |
43,821
+867
| +2% | +$2.94K | ﹤0.01% | 3858 |
|
|
2024
Q3 | $122K | Buy |
42,954
+5,454
| +15% | +$15.5K | ﹤0.01% | 4064 |
|
|
2024
Q2 | $84.4K | Buy |
37,500
+11,927
| +47% | +$26.8K | ﹤0.01% | 4256 |
|
|
2024
Q1 | $56.5K | Buy |
25,573
+7,150
| +39% | +$15.8K | ﹤0.01% | 4646 |
|
|
2023
Q4 | $43.3K | Sell |
18,423
-3,611
| -16% | -$8.49K | ﹤0.01% | 4991 |
|
|
2023
Q3 | $41K | Buy |
22,034
+5,627
| +34% | +$10.5K | ﹤0.01% | 5115 |
|
|
2023
Q2 | $43K | Buy |
16,407
+5,500
| +50% | +$14.4K | ﹤0.01% | 5028 |
|
|
2023
Q1 | $17.8K | Hold |
10,907
| – | – | ﹤0.01% | 5616 |
|
|
2022
Q4 | $15K | Sell |
10,907
-15,425
| -59% | -$21.2K | ﹤0.01% | 5735 |
|
|
2022
Q3 | $41K | Sell |
26,332
-400
| -1% | -$623 | ﹤0.01% | 5043 |
|
|
2022
Q2 | $42K | Buy |
26,732
+22,632
| +552% | +$35.6K | ﹤0.01% | 5085 |
|
|
2022
Q1 | $11K | Sell |
4,100
-34,673
| -89% | -$93K | ﹤0.01% | 6057 |
|
|
2021
Q4 | $113K | Buy |
38,773
+10,697
| +38% | +$31.2K | ﹤0.01% | 4495 |
|
|
2021
Q3 | $69K | Sell |
28,076
-3,559
| -11% | -$8.75K | ﹤0.01% | 4850 |
|
|
2021
Q2 | $129K | Buy |
31,635
+7,515
| +31% | +$30.6K | ﹤0.01% | 4257 |
|
|
2021
Q1 | $109K | Buy |
24,120
+16,350
| +210% | +$73.9K | ﹤0.01% | 4266 |
|
|
2020
Q4 | $39K | Buy |
7,770
+4,000
| +106% | +$20.1K | ﹤0.01% | 4719 |
|
|
2020
Q3 | $22K | Buy |
3,770
+200
| +6% | +$1.17K | ﹤0.01% | 4847 |
|
|
2020
Q2 | $9K | Buy |
+3,570
| New | +$9K | ﹤0.01% | 5201 |
|